ADO 0.00% 2.1¢ anteotech ltd

Nanotechnology innovation in Point of Care testing - by Marcel van Kasteel, CEO Handheld Diagnostic, page-18

  1. 5,687 Posts.
    BBI - lateral flow tests with Mix & Go "rivalled those that are achieved, for the antibodies tested, in laboratory-based test"

    POC1 - instrument based tests "expected to deliver a range of test performance levels that are comparable to many laboratory-based tests"

    So ADO have both camps covered.
 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
(20min delay)
Last
2.1¢
Change
0.000(0.00%)
Mkt cap ! $51.83M
Open High Low Value Volume
2.1¢ 2.2¢ 2.1¢ $3.414K 161.6K

Buyers (Bids)

No. Vol. Price($)
4 384663 2.1¢
 

Sellers (Offers)

Price($) Vol. No.
2.2¢ 616353 6
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
ADO (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.